You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 299 No. 11, March 19, 2008 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •eTable
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (20)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Venous Thromboembolism
 •Cardiovascular System
 •Genetics
 •Genetic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Gene Variants Associated With Deep Vein Thrombosis

Irene D. Bezemer, MSc; Lance A. Bare, PhD; Carine J. M. Doggen, PhD; Andre R. Arellano, BS; Carmen Tong, BS; Charles M. Rowland, MS; Joseph Catanese, BS; Bradford A. Young, PhD; Pieter H. Reitsma, PhD; James J. Devlin, PhD; Frits R. Rosendaal, MD, PhD

JAMA. 2008;299(11):1306-1314.

Context  The genetic causes of deep vein thrombosis (DVT) are not fully understood.

Objective  To identify single-nucleotide polymorphisms (SNPs) associated with DVT.

Design, Setting, and Patients  We used 3 case-control studies of first DVT. A total of 19 682 gene-centric SNPs were genotyped in 443 cases and 453 controls from the Leiden Thrombophilia Study (LETS, 1988-1992). Twelve hundred six SNPs associated with DVT were reinvestigated in the Multiple Environmental and Genetic Assessment of Risk Factors for Venous Thrombosis study (MEGA-1, 1999-2004) in a subset of 1398 cases and 1757 controls. Nine SNPs associated with DVT in both LETS and MEGA-1 were investigated a third time in 1314 cases and 2877 controls from MEGA-2, a second subset of MEGA. Additional SNPs close to one SNP in CYP4V2 were genotyped in LETS and MEGA-1.

Main Outcome Measure  Odds ratios (ORs) for DVT were estimated by logistic regression. False discovery rates served to investigate the effect of multiple hypothesis testing.

Results  Of 9 SNPs genotyped in MEGA-2, 3 were strongly associated with DVT (P < .05; false discovery rate ≤.10): rs13146272 in CYP4V2 (risk allele frequency, 0.64), rs2227589 in SERPINC1 (risk allele frequency, 0.10), and rs1613662 in GP6 (risk allele frequency, 0.84). The OR for DVT per risk allele was 1.24 (95% confidence interval [95%CI], 1.11-1.37) for rs13146272, 1.29 (95% CI, 1.10-1.49) for rs2227589, and 1.15 (95% CI, 1.01-1.30) for rs1613662. In the region of CYP4V2, we identified 4 additional SNPs (in CYP4V2, KLKB1, and F11) that were also associated with both DVT (highest OR per risk allele, 1.39; 95% CI, 1.11-1.74) and coagulation factor XI level (highest increase per risk allele, 8%; 95% CI, 5%-11%).

Conclusions  We identified SNPs in several genes that were associated with DVT. We also found SNPs in the region around the SNP in CYP4V2 (rs13146272) that were associated with both DVT and factor XI levels. These results show that common genetic variation plays an important role in determining thrombotic risk.


Author Affiliations: Department of Clinical Epidemiology (Ms Bezemer and Drs Doggen and Rosendaal), Einthoven Laboratory for Experimental Vascular Medicine (Drs Reitsma and Rosendaal), and Department of Thrombosis and Hemostasis (Drs Reitsma and Rosendaal), Leiden University Medical Center, Leiden, the Netherlands; and Celera, Alameda, California (Drs Bare, Young, and Devlin, Mssrs Arellano, Rowland, and Catanese, and Ms Tong).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Gene Discovery in Venous Thrombosis: Progress and Promise
Edwin G. Bovill
JAMA. 2008;299(11):1362-1363.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High coagulant factors & venous thrombosis
Doggen
Blood 2009;114:2854-2855.
FULL TEXT  

Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology
Cushman et al.
Blood 2009;114:2878-2883.
ABSTRACT | FULL TEXT  

Update on acute pulmonary embolism
Sanchez et al.
ERR 2009;18:137-147.
FULL TEXT  

Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach
Tregouet et al.
Blood 2009;113:5298-5303.
ABSTRACT | FULL TEXT  

Factor IX and deep vein thrombosis
Lowe
haematol 2009;94:615-617.
FULL TEXT  

F9 Malmo, factor IX and deep vein thrombosis
Bezemer et al.
haematol 2009;94:693-699.
ABSTRACT | FULL TEXT  

Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels
Anton et al.
haematol 2009;94:589-592.
ABSTRACT | FULL TEXT  

An Evaluation of Candidate Genes of Inflammation and Thrombosis in Relation to the Risk of Venous Thromboembolism: The Women's Genome Health Study
Zee et al.
Circ Cardiovasc Genet 2009;2:57-62.
ABSTRACT | FULL TEXT  

Gene Discovery in Venous Thrombosis: Progress and Promise
Bovill
JAMA 2008;299:1362-1363.
FULL TEXT  

Genetics and Genomics for Clinicians
Fontanarosa et al.
JAMA 2008;299:1364-1365.
FULL TEXT  

Probing the Genetics of Deep Venous Thrombosis
Journal Watch Cardiology 2008;2008:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.